Purpose
The aim of the study is to develop modified, branched versions of the Noyes–Whitney and the Weibull equations, including explicitly the solubility/dose parameter, for the analysis of dissolution data, which reach the plateau either at infinite or finite time.
Methods
The modified Weibull function is applied to the analysis of experimental and literature dissolution data. To demonstrate the usefulness of the mathematical models, two model drugs are used: one highly soluble, metoprolol, and one relatively insoluble, ibuprofen.
Results
The models were fitted successfully to the data performing better compared with their classic versions. The advantages of the use of the models presented are several. They fit better to a large range of datasets, especially for fast dissolution curves that reach complete dissolution at a finite time. Also, the modified Weibull presented can be derived from differential equations, and it has a physical meaning as opposed to the purely empirical character of the original Weibull equation. The exponent of the Weibull equation can be attributed to the heterogeneity of the process and can be explained by fractal kinetics concepts. Also, the solubility/dose ratio is present explicitly as a parameter and allows to obtain estimates of the solubility even when the dissolution data do not reach the solubility level.
Conclusion
The use of the developed branched equations gives better fittings and specific physical meaning to the dissolution parameters. Also, the findings underline the fact that even in the simplest, first-order case, the speed of the dissolution process depends on the dose, a fact of great importance in biopharmaceutic classification for regulatory purposes.
Similar content being viewed by others
References
A. S. Noyes W. R. Whitney (1897) ArticleTitleThe rate of solution of solid substances in their own solutions J. Am. Chem. Soc. 19 930–934
P. Costa J. M. Sousa Lobo (2001) ArticleTitleModeling and comparison of dissolution profiles Eur. J. Pharm. Sci. 13 123–133 Occurrence Handle1:CAS:528:DC%2BD3MXisF2qs78%3D Occurrence Handle11297896
W. Weibull (1951) ArticleTitleA statistical distribution of wide applicability J. Appl. Mech. 18 293–297
F. Langenbucher (1972) ArticleTitleLinearization of dissolution rate curves by the Weibull distribution J. Pharm. Pharmacol. 24 979–981 Occurrence Handle1:CAS:528:DyaE3sXmt1Wgsg%3D%3D Occurrence Handle4146531
J. A. Goldsmith N. Randall S. D. Ross (1978) ArticleTitleOn methods of expressing dissolution rate data J. Pharm. Pharmacol. 30 347–349 Occurrence Handle1:STN:280:CSeC1MnksF0%3D Occurrence Handle26763
P. Romero J. B. Costa X. Castel-Maroteaux D. Chulia (1991) Statistical optimization of a controlled release formulation obtained by a double compression process: application of a Hadamard matrix and a factorial design J. I. Wells M. H. Rubinstein (Eds) Pharmaceutical Technology, Controlled Drug Release, Vol. 2 Ellis Harwood New York 44–58
G. K. Vudathala J. A. Rogers (1992) ArticleTitleDissolution of fludrocortisone from phospholipid coprecipitates J. Pharm. Sci. 82 282–286
P. V. Pedersen J. W. Myrick (1978) ArticleTitleVersatile kinetic approach to analysis of dissolution data J. Pharm. Sci. 67 1450–1455 Occurrence Handle1:CAS:528:DyaE1cXmtVCis7c%3D Occurrence Handle702301
F. N. Christensen F. Y. Hansen H. Bechgaard (1980) ArticleTitlePhysical interpretation of parameters in the Rosin–Rammler–Sperling–Weibull distribution for drug release from controlled release dosage forms J. Pharm. Pharmacol. 32 580–582 Occurrence Handle1:CAS:528:DyaL3cXmt1Gmuro%3D Occurrence Handle6106699
E. Rinaki A. Dokoumetzidis P. Macheras (2003) ArticleTitleThe mean dissolution time depends on dose/solubility ratio Pharm. Res. 20 406–408 Occurrence Handle1:CAS:528:DC%2BD3sXhslGrtr4%3D Occurrence Handle12669960
P. Lansky M. Weiss (1999) ArticleTitleDoes the dose-solubility ratio affect the mean dissolution time of drugs? Pharm. Res. 16 1470–1476 Occurrence Handle1:CAS:528:DyaK1MXmtVKkurs%3D Occurrence Handle10496667
P. Lansky M. Weiss (2003) ArticleTitleClassification of dissolution profiles in terms of fractional dissolution rate and a novel measure of heterogeneity J. Pharm. Sci. 92 1632–1647 Occurrence Handle1:CAS:528:DC%2BD3sXmtFektro%3D Occurrence Handle12884250
P. Macheras A. Dokoumetzidis (2000) ArticleTitleOn the heterogeneity of drug dissolution and release Pharm. Res. 17 108–112 Occurrence Handle10.1023/A:1007596709657 Occurrence Handle1:CAS:528:DC%2BD3cXitVOqtb8%3D Occurrence Handle10751023
R. Kopelman (1988) ArticleTitleFractal reaction kinetics Science 241 1620–1626 Occurrence Handle1:CAS:528:DyaL1cXlvFyitr0%3D
P. Lansky V. Lanska M. Weiss (2004) ArticleTitleA stochastic differential equation model for drug dissolution and its parameters J. Control. Release 100 267–274 Occurrence Handle10.1016/j.jconrel.2004.08.021 Occurrence Handle1:CAS:528:DC%2BD2cXps1Oqsr8%3D Occurrence Handle15544874
J. E. Polli G. S. Rekhi L. L. Augsburger V. P. Shah (1997) ArticleTitleMethods to compare dissolution profiles and a rationale for wide dissolution specification for metoprolol tablets J. Pharm. Sci. 86 690–700 Occurrence Handle10.1021/js960473x Occurrence Handle1:CAS:528:DyaK2sXjtV2qtb8%3D Occurrence Handle9188051
Official monographs. Ibuprofen, USP XXIV, NF 19, 854–858 (2000).
E. Rinaki G. Valsami P. Macheras (2003) ArticleTitleQuantitative biopharmaceutics classification system: the central role of dose/solubility ratio Pharm. Res. 20 1917–1925 Occurrence Handle1:CAS:528:DC%2BD3sXpvVShsLg%3D Occurrence Handle14725354
E. Rinaki A. Dokoumetzidis G. Valsami P. Macheras (2004) ArticleTitleIdentification of biowaivers among Class II drugs: theoretical justification and practical examples Pharm. Res. 21 1567–1572 Occurrence Handle10.1023/B:PHAM.0000041450.25106.c8 Occurrence Handle1:CAS:528:DC%2BD2cXnsFyjsLs%3D Occurrence Handle15497681
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dokoumetzidis, A., Papadopoulou, V. & Macheras, P. Analysis of Dissolution Data Using Modified Versions of Noyes–Whitney Equation and the Weibull Function. Pharm Res 23, 256–261 (2006). https://doi.org/10.1007/s11095-006-9093-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-006-9093-3